High-Dose Melphalan With or Without Radiolabeled Monoclonal Antibody in Treating Patients With Multiple Myeloma Undergoing an Autologous Stem Cell Transplant

NCT00637767 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

25

Enrollment

OTHER

Sponsor class

Stopped Low recruitment

Conditions

Multiple Myeloma and Plasma Cell Neoplasm

Interventions

DRUG: melphalan
PROCEDURE: autologous hematopoietic stem cell transplantation
RADIATION: yttrium Y 90 anti-CD66 monoclonal antibody BW 250/183

Sponsor

University of Southampton

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]